Targeting aging for disease modification in osteoarthritis.

Area of Science:

• Biomedical science
• Gerontology
• Rheumatology

Background:

• Age is a primary risk factor for osteoarthritis (OA).
• Age-related joint changes are potential therapeutic targets.
• Understanding aging's role in OA is crucial for disease modification.

Purpose of the Study:

• Review recent literature on aging's role in OA.
• Identify insights into OA pathogenesis related to aging.
• Focus on potential disease-modifying therapeutic strategies.

Main Methods:

• Literature review of studies on aging and OA.
• Analysis of preclinical data from cell and animal models.
• Examination of cellular senescence and mitochondrial dysfunction in OA.

Main Results:

• Cellular senescence and mitochondrial dysfunction are hallmarks of aging contributing to OA.
• Senescent cells release pro-inflammatory and matrix-degrading factors.
• Mitochondrial dysfunction increases reactive oxygen species (ROS), disrupting cellular signaling.

Conclusions:

• Targeting cellular senescence and mitochondrial dysfunction shows promise for OA treatment.
• Senolytic compounds offer a potential disease-modifying therapy.
• Reducing ROS and modulating redox signaling may slow OA progression.